COMPARATIVE PHYSICAL STUDIES OF ATENOLOL BRANDS AVAILABLE IN LIBYAN DRUG MARKET

Abdulrhman Ahmed Akasha

Abstract


Atenolol is a cardioselective beta1-adrenergic receptor blocking agent prescribed for treatment of hypertension, angina pectoris and cardiac arrhythmias. However, there are many Atenolol brands marketed in Libya. The objective of this study was to evaluate the quality of five commercial Atenolol (100 mg) products available on the Libyan market. We carried out a survey on the price of all Atenolol tablet products and assessed their quality. To assess quality, all products were examined visually for their organoleptic properties, tested for weight uniformity, friability, disintegration, and moisture content assayed. We carried out a physical comparison of all Atenolol tablet products and assessed their quality. To assess quality, all products of Atenolol such as: Atenolol tablets, Actavis United Kingdom, Totamol  tablets WOCKHARDT , United Kingdom, Atenolol Normon  Spain, Atenolol Film Coated tablets, BRISTOL, United Kingdom and Hypoten  tablets, HIKMA Amman–Jordan.  Based on our testing procedure, all Atenolol five brands were showed the fulfilment of the compendial specification for uniformity of weight, disintegration and limit of moisture content, except in case of hardness test all the brands showed softer than Hypoten tablets.  All the brands are within their expiry dates but there is major difference in price. 

Keywords: Atenolol, β-blockers, Hypertension, Friability, Disintegration test,  Libyan market.


Full Text:

PDF

References


Guha S, Avasthi R, Narain VS, Rajendiran C, Mitra M, Ray S, Majumdar D, Mondal MM, Mani S, Mookerjee S, Saha J, Dastidaro DG. A multicentric double blind randomised controlled trial of atenolol versus losartan as first line drug for mild to moderate essential hypertension. J Indian Med Assoc. 2013; 111(12):821-5.

Palatini P, Julius S (2009). "The role of cardiac autonomic function in hypertension and cardiovascular disease". Curr. Hypertens. Rep. 11 (3): 199–205

Edvardsson B. Atenolol in the prophylaxis of chronic migraine: a 3-month open-label study. Springerplus. 2013, 22;2:479.

Lifton, RP; Gharavi, AG, Geller, DS (2001-02-23). "Molecular mechanisms of human hypertension". Cell104 (4): 545–56.

, Sweetman SC (2007) Martindale: The Complete Drug Reference. (35th Edn), Royal Pharmaceutical Society, Pharmaceutical Press, London, UK.

Laurence DR, Bennett PN. Clinical pharmacology. 1992, Seventh Edition:393

Shahnaz Usman, Aftab Alam, Nadda Nadeem, Rameesha Khawar and Zainab Intesar. Biowaiver Studies of Atenolol Tablets (100mg) - An Alternative to In Vivo Bioequivalence Studies,Nat. Prod. Chem. Res2014, 2:1 2329-6836.

Chan, K., Swinden, J. and Donyai, P. Pilot study of the short-term physico-chemical stability of atenolol tablets stored in a multi-compartment compliance aid. European Journal of Hospital Pharmacy Science, (2007), 13 (3): 60-66.

United States Pharmacopeia and National Formulary USP 24–NF 19. Rockville, Maryland, United States Pharmacopeial Convention, Inc., 2000:1882–1883.

Fischer, Karl. "Neues Verfahren zur maßanalytischen Bestimmung des Wassergehaltes von Flüssigkeiten und festen Körpern". Angew. Chem. (1935). 48 (26): 394–396.

Samar AA, Shaimaa A. A comparative study for evaluation of different brands of Metformin Hydrochloride 500 mg tablets marketed in Saudi Arabia. Life Science Journal,2012, 9: 4260-4266.

Bundrick W, Heron SP, Ray P Schiff WM, Tennenberg AM et al. Levofloxacin versus Ciprofloxacin in treatment of chronic bacterial prostatitis : a randomized double-blind multicentre study. Urology, 2003, 62: 537-541.

Zaid AN et al. Interchangeability of two 500 mg amoxicillin capsules with one 1000 mg amoxicillin tablet after a single oral administration. Indian Journal of Pharmaceutical Sciences, 2010, 72:414–420


Refbacks

  • There are currently no refbacks.




Innoriginal: International Journal of Sciences (ISSN: 2349-7041)

____________________________________________________


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.